Matrix metalloproteinases and coronary artery disease: a novel therapeutic target (Q41722548)

8 October 2017

1 reference

title

Matrix metalloproteinases and coronary artery disease: a novel therapeutic target (English)

1 reference

8 October 2017

coronary artery disease

1 reference

Celentano DC

1

1 reference

PubMed ID

9505991

8 October 2017

Frishman WH

series ordinal

2

1 reference

8 October 2017

1 November 1997

1 reference

The Journal of Clinical Pharmacology

8 October 2017

1 reference

8 October 2017

37

1 reference

8 October 2017

11

1 reference

8 October 2017

991-1000

1 reference

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

8 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Matrix metalloproteinases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Regulation of matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Influence of balloon size and stenosis morphology on immediate and delayed elastic recoil after percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

The biology of platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

PDGF ligand and receptor gene expression during repair of arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Clinical application of inhibitors of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in rabbit aortic neointima after selective de-endothelialization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

Isothiazolones interfere with normal matrix metalloproteinase activation and inhibit cartilage proteoglycan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04278.X

10.1002/J.1552-4604.1997.TB04278.X

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9505991